How to Jump-Start Saxenda After a Plateau: Evidence-Based Strategies Experiencing a weight loss plateau whilst taking Saxenda (liraglutide 3.0 mg) is a common challenge that many patients face during their weight management journey
CYP with 150 mg per kg given intraperitoneally caused IC associated with changes in the oxidant-antioxidant balance and inflammation
Celebrate your wins
Beyond those standing concerns, in a press announcement dated March 3, 2026 (FDA.gov press announcement, March 3, 2026), the FDA issued warning letters to 30 telehealth companies for making false or misleading claims about compounded GLP-1 products
As an example, a woman with rheumatoid arthritis was treated with tocilizumab, a humanized monoclonal antibody of class IgG1, targeting interleukin-6 receptors, and developed painful fatty masses of her knees documented by MRI (228)
A statistically significant increase in thyroid C-cell adenomas was observed in males and females at all dose levels, and a statistically significant increase in thyroid C-cell carcinomas was observed in males at .0.01 mg/kg/day, at clinically relevant exposures
